PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK Table of Contents Table of Contents Chapter 28: Peptides, Antimalarial, and Chapter 01: Drug Development and Ethical Considerations Chapter 02: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics Chapter 03: Cultural Considerations Chapter 04: Complementary and Alternative Therapies Chapter 05: Pediatric Considerations Chapter 06: Geriatric Considerations Chapter 07: Drugs in Substance Use Disorder Chapter 08: The Nursing Process and Patient-Centered Care Chapter 09: Safety and Quality Chapter 10: Drug Administration Chapter 11: Drug Calculations Chapter 12: Fluid Volume and Electrolytes Chapter 13: Vitamin and Mineral Replacement Chapter 14: Nutritional Support Chapter 15: Adrenergic Agonists and Antagonists Chapter 16: Cholinergic Agonists and Antagonists Chapter 17: Stimulants Chapter 18: Depressants Chapter 19: Antiseizure Drugs Chapter 20: Drugs for Parkinsonism and Alzheimer's Disease Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms Chapter 22: Antipsychotics and Anxiolytics Chapter 23: Antidepressants and Mood Stabilizers Chapter 24: Antiinflammatories Chapter 25: Analgesics Chapter 26: Antibacterials Chapter 27: Antituberculars, Antifungals, and Antivirals Anthelmintic Chapter 29: HIV- and AIDS-Related Drugs Chapter 30: Transplant Drugs Chapter 31: Vaccines Chapter 32: Anticancer Drugs Chapter 33: Targeted Therapies to Treat Cancer Chapter 34: Biologic Response Modifiers Chapter 35: Upper Respiratory Disorders Chapter 36: Lower Respiratory Disorders Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics Chapter 38: Diuretics Chapter 39: Antihypertensive Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics Chapter 41: Antihyperlipidemics and Peripheral Vasodilators Chapter 42: Gastrointestinal Tract Disorders Chapter 43: Antiulcer Drugs Chapter 44: Eye and Ear Disorders Chapter 45: Dermatologic Disorders Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders Chapter 47: Antidiabetics Chapter 48: Urinary Disorders Chapter 49: Pregnancy and Preterm Labor Chapter 50: Labor, Delivery, and Postpartum Chapter 51: Neonatal and Newborn Chapter 52: Women's Reproductive Health Chapter 53: Men's Reproductive Health Chapter 54: Sexually Transmitted Infections Chapter 55: Adult and Pediatric Emergency Drugs Chapter 01: Drug Development and Ethical Considerations MULTIPLE CHOICE 1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the contents of a Single-use vial. Which nursing action is correct? a. Ask another nurse to observe and cosign wasting the remaining drug from the vial. b. Keep the remaining amount in the patient’s drawer to give at the next dose. c. Record the amount unused in the patient’s medication record. d. Dispose of the vial with the remaining drug into a locked collection box. ANS: A Schedule II drugs are controlled substances, and all must be accounted for. When wasting a portion of a drug, another nurse should observe and cosign that a drug was wasted. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic form. The nurse understands that a generic medication will have a name that a. is a registered trademark. b. is always capitalized. c. describes the drugs chemical structure. d. is non-proprietary. ANS: D The generic name is the official, non-proprietary name for a drug. The brand name is the trademark name and is always capitalized. The chemical name describes the chemical structure of the drug. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 3. A patient receives a prescription on which the provider has noted that a generic medication may be given.The patient asks the nurse what this means. What will the nurse tell the patient about generic drugs? a. They contain the same inert ingredients as brand-name drugs. b. They have chemical structures that are identical to proprietary drugs. c. They tend to be less expensive than brand-name drugs. d. They undergo extensive testing before they are marketed. ANS: C Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand- name drug. They tend to be less expensive because manufacturers of these drugs do not have to do the extensive testing required of brand-name drugs before marketing. They are not identical to brand-name drugs and often have different inert ingredients. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching MSC: NCLEX: Management of Client Care 4. The nurse reviews information about a drug and notes the initials USP after the drugs official name. The nurse understands that this designation indicates the drug a. is a controlled substance. b. is approved by the U.S. Food and Drug Administration (FDA). c. is available in generic form. d. meets quality and safety standards. ANS: D The USP designation is given to drugs that have met high standards for therapeutic use, patient safety, quality, purity, strength, packaging safety, and dosage form by the United States Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman numerals from I to V. The USP designation does not indicate FDA approval. The USP designation does not indicate generic availability. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the drug is safe for children. How will the nurse respond to the parent? a. Drugs are tested on adults and safe doses for children are based on weights compared to adult weights. b. Drugs are deemed safe for children over time when repeated use proves effectiveness and safety. c. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric use. d. Drugs are tested on children in post marketing studies and on a limited basis. ANS: C The Pediatric Research Equity Act requires drug manufacturers to test drugs on children. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 6. Which law(s) govern all drug administration by nurses? a. Drug Regulation and Reform Act b. FDA Amendments Act c. Nurse Practice Acts d. The Controlled Substances Act ANS: C Each states Nurse Practice Act identifies how nurses administer medications. The other acts govern how drugs are marketed and tested. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 7. The nurse administers a drug and miscalculates the dose by placing the decimal place one space to the right, resulting in a 10-fold overdose and the death of the patient. What offense does this represent? a. Malfeasance b. Malpractice c. Misfeasance d. Nonfeasance ANS: C Misfeasance is negligence in giving either the wrong drug or the wrong dose, resulting in the death of the patient. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 8. The nurse is busy and neglects to give a drug to a patient resulting in the patient’s death. What offense does this represent? a. Malfeasance b. Malpractice c. Misfeasance d. Nonfeasance ANS: D Nonfeasance is omitting a drug dose, resulting in the patient’s death. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 9. A patient is taking methadone as part of a heroin withdrawal program. The nurse understands that, in this instance, methadone is classified as which drug schedule? a. C-I b. C-II c. C-III d. C-V ANS: B Methadone is a category II drug, with a high potential for drug abuse. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 10. The nurse is preparing to administer a combination drug containing acetaminophen and codeine. The nurse knows that this drug is classified as which drug schedule? a. C-II b. C-III c. C-IV d. C-V ANS: B Codeine is normally a category II drug, except when it is part of a combination product such as with acetaminophen, making it a category III drug. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: N/A MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 11. The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will last for 6 months. All subjects will be given gift certificates for participating. One subject says, Well, I guess if the drug doesn't work, I'll just have to put up with the symptoms for 6 months. What will the nurse tell the subject? a. Participation for the duration of the study is required. b. Participation may end at any time without penalty. c. Withdrawal from the study may end at any time, but the gift certificate will not be given. d. You can request placement in the treatment group.